Faculty of Pharmacy, PHENIKAA University, Yen Nghia, Ha Dong, Hanoi 12116, Viet Nam; PHENIKAA Institute for Advanced Study (PIAS), PHENIKAA University, Hanoi 12116, Viet Nam.
Faculty of Pharmacy, PHENIKAA University, Yen Nghia, Ha Dong, Hanoi 12116, Viet Nam; PHENIKAA Research and Technology Institute (PRATI), A&A Green Phoenix Group JSC, No.167 Hoang Ngan, Trung Hoa, Cau Giay, Hanoi 11313, Viet Nam.
Life Sci. 2020 Nov 1;260:118407. doi: 10.1016/j.lfs.2020.118407. Epub 2020 Sep 12.
The severe infection is becoming a significant health problem which threaten the lives of patients and the safety and economy of society. In the way of finding new strategy, antimicrobial peptides (AMPs) - an important part of host defense family, emerged with tremendous potential. Up to date, huge numbers of AMPs has been investigated from both natural and synthetic sources showing not only the ability to kill microbial pathogens but also propose other benefits such as wound healing, anti-tumor, immune modulation. In this review, we describe the involvements of AMPs in biological systems and discuss the opportunity in developing AMPs for clinical applications. In the detail, their properties in antibacterial activity is followed by their application in some infection diseases and cancer. The key discussions are the approaches to improve biological activities of AMPs either by modifying chemical structure or incorporating into delivery systems. The new applications and perspectives for the future of AMPs would open the new era of their development.
严重感染正在成为一个重大的健康问题,威胁着患者的生命以及社会的安全和经济。在寻找新策略的过程中,抗菌肽(AMPs)作为宿主防御家族的重要组成部分,具有巨大的潜力。迄今为止,已经从天然和合成来源中研究了大量的 AMPs,它们不仅具有杀死微生物病原体的能力,而且还具有其他益处,如伤口愈合、抗肿瘤、免疫调节。在这篇综述中,我们描述了 AMPs 在生物系统中的作用,并讨论了将 AMPs 开发用于临床应用的机会。详细来说,我们首先介绍了它们在抗菌活性方面的特性,然后讨论了它们在一些感染性疾病和癌症中的应用。重点讨论了通过修饰化学结构或结合到递药系统中来提高 AMPs 生物活性的方法。AMP 未来的新应用和新视角将开辟其发展的新时代。
Microbiol Res. 2024-9
Colloids Surf B Biointerfaces. 2023-5
Drug Resist Updat. 2023-5
Drug Resist Updat. 2016-4-20
Expert Opin Biol Ther. 2013-11-11
Microb Drug Resist. 2018
Front Microbiol. 2025-5-30
Front Cell Infect Microbiol. 2025-4-28
Front Microbiol. 2025-4-23
Recent Adv Antiinfect Drug Discov. 2025
Ann Med Surg (Lond). 2025-3-27
ACS Pharmacol Transl Sci. 2020-6-16
Lancet Infect Dis. 2020-7-9
Science. 2020-5-1
Nat Rev Drug Discov. 2020-2-27
Front Microbiol. 2019-12-12